Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-24 @ 10:01 PM
NCT ID:
NCT02622932
Eligibility Criteria:
Inclusion Criteria:
* signed and dated informed consent
* histologically or cytologically confirmed diagnosis of advanced solid tumor (including RCC、NSCLC、STS and CRC)
* failed to the treatment of line 1 or 2
* ECOG PS:0-1,Life expectancy of more than 3 months
* main organs function is normal
Exclusion Criteria:
* prior treatment with Anlotinib or Allergic to drug or its formulation ingredients
* subjects with the gastrointestinal tract, liver and kidney disease of affect drug absorption and metabolism
* CTCAE(4.0) Grade 1 or higher non-remission toxicity induced by any other previous treatments
* patients with pleural effusion or ascites, causing respiratory syndrome (CTCAE Grade 2 or higher dyspnea \[Grade 2 dyspnea refers to Shortness of breath with a small amount of activities, affecting Instrumental activities of daily life\])
* patients underwent major surgical treatment，open biopsy or significant traumatic injury within 28 days prior to assignment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02622932
Study Brief:
Protocol Section:
NCT02622932